Future Vaccines Depend upon Take a look at Topics in Brief Provide: Monkeys

Mark Lewis was determined to seek out monkeys. Thousands and thousands of human lives, all around the world, had been at stake.

Mr. Lewis, the chief govt of Bioqual, was accountable for offering lab monkeys to pharmaceutical corporations like Moderna and Johnson & Johnson, which wanted the animals to develop their Covid-19 vaccines. However because the coronavirus swept throughout the US final yr, there have been few of the specifically bred monkeys to be discovered anyplace on this planet.

Unable to furnish scientists with monkeys, which might price greater than $10,000 every, a couple of dozen corporations had been left scrambling for analysis animals on the top of the pandemic.

“We misplaced work as a result of we couldn’t provide the animals in the timeframe,” Mr. Lewis stated.

The world wants monkeys, whose DNA carefully resembles that of people, to develop Covid-19 vaccines. However a worldwide scarcity, ensuing from the sudden demand attributable to the pandemic, has been exacerbated by a current ban on the sale of wildlife from China, the main provider of the lab animals.

The newest scarcity has revived speak about making a strategic monkey reserve in the US, an emergency stockpile much like these maintained by the federal government for oil and grain.

As new variants of the coronavirus threaten to make the present batch of vaccines out of date, scientists are racing to seek out new sources of monkeys, and the US is reassessing its reliance on China, a rival with its personal biotech ambitions.

The pandemic has underscored how a lot China controls the provision of lifesaving items, together with masks and drugs, that the United States needs in a crisis.

American scientists have searched private and government-funded facilities in Southeast Asia as well as Mauritius, a tiny island nation off southeast Africa, for stocks of their preferred test subjects, rhesus macaques and cynomolgus macaques, also known as long-tailed macaques.

But no country can make up for what China previously supplied. Before the pandemic, China provided over 60 percent of the 33,818 primates, mostly cynomolgus macaques, imported into the United States in 2019, according to analyst estimates based on data from the Centers for Disease Control and Prevention.

The United States has as many 25,000 lab monkeys — predominantly pink-faced rhesus macaques — at its seven primate centers. About 600 to 800 of those animals have been subject to coronavirus research since the pandemic began.

Eventually, they landed on China.

The pandemic upset what had been a decades-long relationship between American scientists and Chinese suppliers.

“Our idea was sort of like the strategic oil reserve, in that there’s lots and lots of fuel somewhere that is only tapped in an emergency,” Professor Bohm said.

But as new variants of the virus are discovered, potentially restarting the race for a vaccine, scientists say the government needs to take action on the stockpile immediately.

“The strategic monkey reserve is exactly what we needed to deal with Covid, and we just didn’t have it,” said Keith Reeves, a principal investigator at the Center for Virology and Vaccine Research at Harvard Medical School.

But a robust strategic reserve might still be unable to meet the skyrocketing demand for lab animals, as researchers in China have learned. Even with a government-controlled stockpile of about 45,000 monkeys, researchers in China say they are also grappling with a shortage.

Researchers often collect hundreds of specimens from a single monkey, whose tissues can be frozen for years and studied over long periods. The scientists say they make the most of each animal, but monkeys infected with Covid-19 cannot be returned to live among other healthy animals and must be eventually euthanized.

In January, Shen Weiguo, general manager of the Shanghai Technology Venture Capital Group, told local legislators that three large biomedical companies in the city were short 2,750 research monkeys last year, according to a report in the state news media. The shortfall is expected to grow 15 percent annually over the next five years, Mr. Shen said.

Hubei Topgene Biotechnology raises monkeys for its own research and for export. The United States was previously its top export destination, but the company currently does not have enough animals to conduct its own experiments, said Yan Shuo, a sales manager.

“Now, it’s not even a matter of money,” Mr. Yan said. “We don’t even have monkeys to sell abroad.”

The United States maintains seven national primate research centers, where the animals, when not undergoing research, live in colonies with access to the outdoors and enrichment activities. The facilities are affiliated with research universities and funded by the National Institutes of Health. Animal rights activists have long accused the centers of abuse, including separating babies from their mothers.

Matthew R. Bailey, president of the National Association for Biomedical Research, said he was preparing to raise the monkey shortage with the Biden administration. He said China’s decision to halt exports at the beginning of the pandemic was “likely a prudent emergency move,” but he suggested that China could restart exports given what is now known about how the virus is spread.

China’s Foreign Ministry said the ban was not targeted at specific species or countries.

Once the international situation improves and the conditions for imports and exports are met,” the ministry said in a statement, “China will actively consider resuming import and export approval and other related work.”

Experts said the United States had to bear some responsibility for not having enough research monkeys.

The budgets at the national primate centers have either stayed flat or fallen for well over a decade. Koen Van Rompay, an infectious diseases expert at the California National Primate Research Center, said the federal government asked the center to expand its breeding colonies about 10 years ago but did not give it increased funding, so it downsized its colony instead.

“What we did in a number of cases was that we gave our females birth control,” Dr. Van Rompay said. “So there would be fewer babies born in the spring.”

At a panel organized by the National Institutes of Health in December 2018, scientists discussed the challenges facing America’s primate supply. There was an awareness then that “if China decides to turn off the spigot, we will be in deep trouble,” said Jeffrey Roberts, the associate director of the California National Primate Research Center.

Attendees “agreed that the need to domestically breed cynomolgus macaques is essential and could jeopardize biomedical research in the United States as a whole, if not met,” according to a report of the meeting. “They emphasized that it may already be too late to address this need but will certainly be too late within a few months.”

Amber Wang and Elsie Chen contributed research.

Source link